| Name | HP1142 |
|---|
| Description | HP1142 is a potent and selective inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1142 is a benzoimidazole scaffold-based compound. HP1142 has the potential for the research of FLT3/ITD leukemia[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H21N3O2 |
|---|---|
| Molecular Weight | 359.42 |